Delivery Order V797D70255-36C24526N0514
Award Date 4/15/26
Potential Completion Date 4/17/26
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,800 to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product. The contract was awarded on March 18, 2026, with an ultimate completion date of March 20, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA healthcare operations. This delivery order operates under a firm fixed-price arrangement with no...
- Galderma Laboratories, L.P., a foreign-owned pharmaceutical manufacturer based in Dallas, Texas, received a $31.8K delivery order from Veterans Integrated Service Network 5 (VISN 5) for NEMLUVIO 30 mg. The contract, awarded on December 2, 2025, with a completion date of December 3, 2025, represents a firm fixed-price arrangement with no set-aside designation. This delivery order falls under the broader Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General...
- Galderma Laboratories, L.P. was awarded a delivery order valued at $46,697.40 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of NEMLUVIO 30 mg pharmaceutical product. The contract, awarded on September 19, 2025, with an ultimate completion date of September 23, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed through the Pharmaceuticals and Drugs Federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.24 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 10, 2025, with completion scheduled for January 2, 2026. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nemluvio (bimekizumab), a biologic medication used in the treatment of inflammatory skin conditions, represents a specialty pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 29, 2025, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract calls for the supply of Nemluvio, a pharmaceutical product used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 11, 2025, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nemluvio (nemtabrutinib) is a targeted therapy used in the treatment of certain hematologic malignancies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens with a ceiling value of $2,033.08. This contract, with an award date of December 18, 2025 and ultimate completion date of January 12, 2026, is a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- On January 16, 2026, the Defense Logistics Agency awarded a $8,132.32 delivery order (Contract No. 4570541335) to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order is scheduled for ultimate completion on February 9, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $3,735.44 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens under a firm fixed-price contract type. The contract is effective as of November 14, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, single-source delivery order issued without a set-aside designation. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 23, 2025, with completion targeted for January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The contract calls for pharmaceutical product delivery to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....